|
|
Volumn 325, Issue 7356, 2002, Pages
|
|
Are selective COX 2 inhibitors superior to traditional NSAIDs? Rofecoxib did not provide unequivocal benefit over traditional NSAIDs.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
LACTONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
ROFECOXIB;
SULFONAMIDE;
SULFONE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
GASTROINTESTINAL DISEASE;
HUMAN;
NOTE;
RHEUMATOID ARTHRITIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS;
CYCLOOXYGENASE INHIBITORS;
GASTROINTESTINAL DISEASES;
HUMANS;
LACTONES;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
|
|
EID: 85007664425
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.325.7356.161 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
